Baker Bros bags $340m from BeiGene block

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Baker Bros bags $340m from BeiGene block

Rashmi Kumar
December 02, 2020 06:15 AM
biopharma_stocks_adobe_575x375.jpg
Healthcare medical biopharmaceutical investing stock chart background | Kurhan - stock.adobe.com

Baker Bros Advisors, a shareholder in Chinese biopharmaceutical company BeiGene, has raised $340.1m from a sell-down of the firm’s American depositary shares.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Health and BiotechEquityChinaAmericasAsiaGreater ChinaNortheast AsiaAsia PacificABBs-Block TradesUnited StatesEmerging MarketsNorth AmericaSRIGoldman Sachs
RK
Rashmi Kumar
Gift this article